Opus Genetics Reports Positive Pediatric Data from OPGx-LCA5 Phase 1/2 Trial in Leber Congenital Amaurosis Type 5 (LCA5)

Pediatric participants demonstrated large gains in cone-mediated vision; therapy remains well tolerated with no ocular ...